Literature DB >> 26453266

Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies.

Jiabi Qin1, Xiaoying Liu2, Xiaoqi Sheng3, Hua Wang3, Shiyou Gao4.   

Abstract

OBJECTIVE: To determine whether there are any increases in pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies after assisted reproductive technology (ART) compared with those conceived naturally.
DESIGN: Meta-analysis.
SETTING: University-affiliated teaching hospital. PATIENT(S): Singleton pregnancies conceived with ART and naturally. INTERVENTION(S): PubMed, Google Scholar, Cochrane Libraries and Chinese database were searched through March 2015 to identify studies that met pre-stated inclusion criteria. Either a fixed- or a random-effects model was used to calculate the overall combined risk estimates. Subgroup analysis was performed to explore potential heterogeneity moderators. MAIN OUTCOME MEASURE(S): Pregnancy-related complications and adverse pregnancy outcomes. RESULT(S): Fifty cohort studies comprising 161,370 ART and 2,280,241 spontaneously conceived singleton pregnancies were identified. The ART singleton pregnancies had a significantly increased risk of pregnancy-induced hypertension (relative risk [RR] 1.30, 95% confidence interval [CI] 1.04-1.62; I(2) = 79%), gestational diabetes mellitus (RR 1.31, 95% CI 1.13-1.53; I(2) = 6%), placenta previa (RR 3.71, 95% CI 2.67-5.16; I(2) = 72%), placental abruption (RR 1.83, 95% CI 1.49-2.24; I(2) = 22%), antepartum hemorrhage (RR 2.11, 95% CI 1.86-2.38; I(2) = 47%), postpartum hemorrhage (RR 1.29, 95% CI 1.06-1.57; I(2) = 65%), polyhydramnios (RR 1.74, 95% CI 1.24-2.45; I(2) = 0%), oligohydramnios (RR 2.14, 95% CI 1.53-3.01; I(2) = 0%), cesarean sections (RR 1.58, 95% CI 1.48-1.70; I(2) = 92%), preterm birth (RR 1.71, 95% CI 1.59-1.83; I(2)=80%), very preterm birth (RR 2.12, 95% CI 1.73-2.59; I(2) = 90%), low birth weight (RR 1.61, 95% CI 1.49-1.75; I(2) = 80%), very low birth weight (RR 2.12, 95% CI 1.84-2.43; I(2) = 67%), small for gestational age (RR 1.35, 95% CI 1.20-1.52; I(2) = 82%), perinatal mortality (RR 1.64, 95% CI 1.41-1.90; I(2)=45%), and congenital malformation (RR 1.37, 95% CI 1.29-1.45; I(2)=41%). Relevant heterogeneity moderators have been identified by subgroup analysis. Sensitivity analysis yielded consistent results. No evidence of publication bias was observed. CONCLUSION(S): The ART singleton pregnancies are associated with higher risks of adverse obstetric outcomes. Obstetricians should manage these pregnancies as high risk.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse pregnancy outcomes; assisted reproductive technology; meta-analysis; pregnancy-related complications; singleton pregnancies

Mesh:

Year:  2015        PMID: 26453266     DOI: 10.1016/j.fertnstert.2015.09.007

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  89 in total

1.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

2.  Increased pregnancy complications following frozen-thawed embryo transfer during an artificial cycle.

Authors:  Shuang Jing; Xiao Feng Li; Shuoping Zhang; Fei Gong; Guangxiu Lu; Ge Lin
Journal:  J Assist Reprod Genet       Date:  2019-03-29       Impact factor: 3.412

Review 3.  Tracking placental development in health and disease.

Authors:  John D Aplin; Jenny E Myers; Kate Timms; Melissa Westwood
Journal:  Nat Rev Endocrinol       Date:  2020-06-29       Impact factor: 43.330

4.  First trimester pregnancy ultrasound findings as a function of method of conception in an infertile population.

Authors:  Frauke von Versen-Höynck; Jenna S Petersen; Yueh-Yun Chi; Jing Liu; Valerie L Baker
Journal:  J Assist Reprod Genet       Date:  2018-01-29       Impact factor: 3.412

5.  The hypomethylation of imprinted genes in IVF/ICSI placenta samples is associated with concomitant changes in histone modifications.

Authors:  Cécile Choux; Paolo Petazzi; Marta Sanchez-Delgado; José R Hernandez Mora; Ana Monteagudo; Paul Sagot; David Monk; Patricia Fauque
Journal:  Epigenetics       Date:  2020-06-23       Impact factor: 4.528

6.  Collection of pregnancy outcome records following infertility-challenges and possible solutions.

Authors:  Erin G Floyd; Frauke von Versen-Höynck; Jing Liu; Yueh-Yun Chi; Raquel R Fleischmann; Valerie L Baker
Journal:  J Assist Reprod Genet       Date:  2016-05-26       Impact factor: 3.412

7.  Increased risk of large-for-gestational age birthweight in singleton siblings conceived with in vitro fertilization in frozen versus fresh cycles.

Authors:  Barbara Luke; Morton B Brown; Ethan Wantman; Judy E Stern; James P Toner; Charles C Coddington
Journal:  J Assist Reprod Genet       Date:  2016-12-01       Impact factor: 3.412

8.  Failure of fertility therapy and subsequent adverse cardiovascular events.

Authors:  Jacob A Udell; Hong Lu; Donald A Redelmeier
Journal:  CMAJ       Date:  2017-03-13       Impact factor: 8.262

9.  The live birth and neonatal outcomes in the subsequent pregnancy among patients with adverse pregnancy outcomes in first frozen embryo transfer cycles.

Authors:  Jianghui Li; Jiaying Lin; Mingru Yin; Qianqian Zhu; Yanping Kuang
Journal:  Arch Gynecol Obstet       Date:  2020-05-28       Impact factor: 2.344

10.  Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis.

Authors:  Costas Thomopoulos; George Salamalekis; Konstantinos Kintis; Iliana Andrianopoulou; Helena Michalopoulou; George Skalis; Stefanos Archontakis; Ourania Argyri; Costas Tsioufis; Thomas K Makris; Emmanuel Salamalekis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.